Acadia Healthcare Company Future Growth
Future criteria checks 2/6
Acadia Healthcare Company is forecast to grow earnings and revenue by 11.6% and 8.5% per annum respectively. EPS is expected to grow by 10.1% per annum. Return on equity is forecast to be 10.1% in 3 years.
Key information
11.6%
Earnings growth rate
10.1%
EPS growth rate
Healthcare earnings growth | 27.6% |
Revenue growth rate | 8.5% |
Future return on equity | 10.1% |
Analyst coverage | Good |
Last updated | 22 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,769 | 367 | N/A | N/A | 10 |
12/31/2025 | 3,443 | 328 | 20 | 577 | 12 |
12/31/2024 | 3,160 | 295 | -517 | 126 | 12 |
9/30/2024 | 3,123 | 281 | -496 | 129 | N/A |
6/30/2024 | 3,057 | -5 | -459 | 104 | N/A |
3/31/2024 | 2,993 | -11 | -403 | 97 | N/A |
12/31/2023 | 2,929 | -22 | 38 | 462 | N/A |
9/30/2023 | 2,861 | -18 | 87 | 460 | N/A |
6/30/2023 | 2,778 | 271 | 42 | 363 | N/A |
3/31/2023 | 2,698 | 278 | 36 | 348 | N/A |
12/31/2022 | 2,610 | 273 | 84 | 381 | N/A |
9/30/2022 | 2,529 | 282 | 68 | 365 | N/A |
6/30/2022 | 2,449 | 277 | 170 | 434 | N/A |
3/31/2022 | 2,380 | 242 | 139 | 375 | N/A |
12/31/2021 | 2,314 | 203 | 130 | 374 | N/A |
9/30/2021 | 2,262 | 192 | 250 | 463 | N/A |
6/30/2021 | 2,223 | 162 | 337 | 560 | N/A |
3/31/2021 | 2,132 | 144 | 464 | 689 | N/A |
12/31/2020 | 2,090 | 140 | 434 | 659 | N/A |
9/30/2020 | 1,230 | 14 | 400 | 592 | N/A |
6/30/2020 | 1,459 | 20 | 269 | 469 | N/A |
3/31/2020 | 1,757 | 41 | 121 | 335 | N/A |
12/31/2019 | 2,008 | 52 | 100 | 333 | N/A |
9/30/2019 | 3,071 | -211 | 47 | 341 | N/A |
6/30/2019 | 3,054 | -208 | 6 | 325 | N/A |
3/31/2019 | 3,031 | -197 | 45 | 385 | N/A |
12/31/2018 | 1,905 | 57 | 161 | 414 | N/A |
9/30/2018 | 2,993 | 226 | 84 | 414 | N/A |
6/30/2018 | 2,949 | 225 | N/A | 429 | N/A |
3/31/2018 | 2,899 | 216 | N/A | 415 | N/A |
12/31/2017 | 2,836 | 200 | N/A | 400 | N/A |
9/30/2017 | 2,815 | 172 | N/A | 373 | N/A |
6/30/2017 | 2,833 | 9 | N/A | 366 | N/A |
3/31/2017 | 2,873 | 15 | N/A | 360 | N/A |
12/31/2016 | 2,811 | 6 | N/A | 361 | N/A |
9/30/2016 | 2,603 | -1 | N/A | 358 | N/A |
6/30/2016 | 2,348 | 146 | N/A | 332 | N/A |
3/31/2016 | 2,046 | 124 | N/A | 281 | N/A |
12/31/2015 | 1,794 | 112 | N/A | 240 | N/A |
9/30/2015 | 1,594 | 100 | N/A | 188 | N/A |
6/30/2015 | 1,409 | 96 | N/A | 177 | N/A |
3/31/2015 | 1,169 | 85 | N/A | 126 | N/A |
12/31/2014 | 1,005 | 83 | N/A | 115 | N/A |
9/30/2014 | 900 | 73 | N/A | 88 | N/A |
6/30/2014 | 790 | 62 | N/A | 66 | N/A |
3/31/2014 | 754 | 52 | N/A | 72 | N/A |
12/31/2013 | 713 | 43 | N/A | 66 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7RA's forecast earnings growth (11.6% per year) is above the savings rate (1%).
Earnings vs Market: 7RA's earnings (11.6% per year) are forecast to grow slower than the German market (20.9% per year).
High Growth Earnings: 7RA's earnings are forecast to grow, but not significantly.
Revenue vs Market: 7RA's revenue (8.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 7RA's revenue (8.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7RA's Return on Equity is forecast to be low in 3 years time (10.1%).